COLUMBO LIMITED
Company number 04386468 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Investment Risk Analysis: Columbo Limited (04386468)
1. Risk Rating: HIGH
The accounts are significantly overdue, with the most recent filed financial data dating back to 2017 — representing an approximately seven-year gap in publicly available financial information. Combined with substantial director dividends extracted during a period of moderate leverage, a complex multi-entity ownership structure, and recent board turnover, the risk profile is elevated.
2. Key Concerns
i. Severe Filing Delinquency and Information Opacity
The accounts are marked as overdue, with the last filed accounts covering the period to 31 December 2017. Despite a stated accounting reference date of 31 December 2024, no subsequent financial statements appear on the public record. This creates a near-total information vacuum for investors regarding the company's current solvency, liquidity, and trading performance. The 2017 accounts themselves were not approved until 21 March 2019, indicating a historical pattern of late filing.
ii. Aggressive Dividend Extraction
During the 9-month period to 31 December 2017, £134,000 in dividends was paid to the directors — a substantial extraction relative to net assets of £79,021 and cash balances of £16,104. This level of distribution, in a company with £216,946 in current liabilities and £73,447 in long-term hire purchase obligations, raises questions about whether distributions were made from genuine distributable reserves or at the expense of creditor security.
iii. Rising Hire Purchase Obligations and Leverage
Hire purchase commitments increased dramatically from £10,128 (March 2017) to £133,500 (December 2017), with £60,053 due within one year. This represents a significant increase in financed obligations that could strain working capital, particularly given that trade debtors of £277,672 substantially exceed cash on hand. The company's ability to convert receivables into cash is critical, and no current data is available to assess this.
3. Positive Indicators
- Positive Net Assets: As of the last filed accounts, net assets stood at £79,021, an improvement from £32,652 in the prior period, suggesting the business was generating retained earnings.
- Positive Working Capital: Net current assets of £117,238 indicate the company maintained a short-term asset buffer over current liabilities at the last reporting date.
- Long Operating History: Incorporated in 2002, the company has over two decades of trading history in the human health activities sector (SIC 86900), which typically demonstrates some operational resilience.
- Confirmation Statement Current: The confirmation statement is up to date (last made up 1 October 2026), suggesting the company is maintaining basic statutory compliance on the corporate register side.
4. Due Diligence Notes
- Obtain Post-2017 Financial Statements: The single most critical action is to obtain or reconstruct financial data for the period 2018–2024. Without this, any assessment of current solvency is based on stale information. Investigate whether accounts have been filed late and are pending publication, or whether the company has failed to file entirely.
- Examine PSC Structure: The ownership structure involves multiple corporate entities — Jac All Investments Limited, Lopsided Ltd, and Ho2 Management Limited (which holds >75%) — alongside individual PSCs (name shown to subscribers and name shown to subscribers). Investigate the financial health of these parent/holding entities and whether intercompany transactions exist.
- Director Resignation Context: name shown to subscribers resigned as director on 30 September 2026. Given his significant influence and shareholding (25–50%), the circumstances of his departure and the appointment of new directors (name shown to subscribers, name shown to subscribers) warrant investigation — particularly whether this reflects a genuine succession or a restructuring of control.
- Debtor Quality and Collection: Trade debtors of £277,672 represented 83% of current assets in 2017. Assess the ageing profile, concentration risk, and historical bad debt experience. A deterioration in debtor quality could rapidly erode the working capital position.
- Regulatory Compliance in Healthcare: As a company engaged in "other human health activities" (SIC 86900), verify current CQC registration status and any regulatory actions, as compliance failures in this sector can have immediate financial and operational consequences.
- Hire Purchase Asset Security: Clarify what assets are subject to the £133,500 in hire purchase obligations and whether the financed equipment is essential to operations. Loss of financed assets through default would directly impact service delivery capacity.